European Journal of Clinical Investigation

Cover image for Vol. 39 Issue s2

Special Issue: Update on endothelin-related diseases

June 2009

Volume 39, Issue Supplement s2

Pages 1–87

  1. Update on endothelin-related diseases This Supplement was sponsored by an unrestricted educational grant from Encysive Pharmaceuticals Inc. In June 2008 Encysive was acquired by Pfi zer Inc.

    1. Top of page
    2. Update on endothelin-related diseases This Supplement was sponsored by an unrestricted educational grant from Encysive Pharmaceuticals Inc. In June 2008 Encysive was acquired by Pfi zer Inc.
    3. ORIGINAL ARTICLES
    4. REVIEW ARTICLE
    5. ORIGINAL ARTICLE
    6. REVIEW ARTICLE
    7. ORIGINAL ARTICLES
    8. REVIEW ARTICLES
    9. ORIGINAL ARTICLE
    1. EDITORIAL

      Update on endothelin-related diseases (pages 1–2)

      D. Pittrow and W. Kirch

      Version of Record online: 24 MAR 2009 | DOI: 10.1111/j.1365-2362.2009.02114.x

  2. ORIGINAL ARTICLES

    1. Top of page
    2. Update on endothelin-related diseases This Supplement was sponsored by an unrestricted educational grant from Encysive Pharmaceuticals Inc. In June 2008 Encysive was acquired by Pfi zer Inc.
    3. ORIGINAL ARTICLES
    4. REVIEW ARTICLE
    5. ORIGINAL ARTICLE
    6. REVIEW ARTICLE
    7. ORIGINAL ARTICLES
    8. REVIEW ARTICLES
    9. ORIGINAL ARTICLE
    1. Endothelin receptor antagonists in preclinical models of pulmonary hypertension (pages 3–13)

      S. S. Pullamsetti and R. T. Schermuly

      Version of Record online: 24 MAR 2009 | DOI: 10.1111/j.1365-2362.2009.02115.x

    2. Interaction of acenocoumarol and sitaxentan in pulmonary arterial hypertension (pages 14–18)

      T. Pulido, J. Sandoval, I. Roquet, R. Gutiérrez, T. Rueda, H. Peña, E. Santos, M. T. Miranda and E. Lupi

      Version of Record online: 24 MAR 2009 | DOI: 10.1111/j.1365-2362.2009.02116.x

  3. REVIEW ARTICLE

    1. Top of page
    2. Update on endothelin-related diseases This Supplement was sponsored by an unrestricted educational grant from Encysive Pharmaceuticals Inc. In June 2008 Encysive was acquired by Pfi zer Inc.
    3. ORIGINAL ARTICLES
    4. REVIEW ARTICLE
    5. ORIGINAL ARTICLE
    6. REVIEW ARTICLE
    7. ORIGINAL ARTICLES
    8. REVIEW ARTICLES
    9. ORIGINAL ARTICLE
    1. You have free access to this content
      Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma (pages 19–26)

      X. Shiwen, A. Leask, D. J. Abraham and C. Fonseca

      Version of Record online: 24 MAR 2009 | DOI: 10.1111/j.1365-2362.2009.02117.x

  4. ORIGINAL ARTICLE

    1. Top of page
    2. Update on endothelin-related diseases This Supplement was sponsored by an unrestricted educational grant from Encysive Pharmaceuticals Inc. In June 2008 Encysive was acquired by Pfi zer Inc.
    3. ORIGINAL ARTICLES
    4. REVIEW ARTICLE
    5. ORIGINAL ARTICLE
    6. REVIEW ARTICLE
    7. ORIGINAL ARTICLES
    8. REVIEW ARTICLES
    9. ORIGINAL ARTICLE
  5. REVIEW ARTICLE

    1. Top of page
    2. Update on endothelin-related diseases This Supplement was sponsored by an unrestricted educational grant from Encysive Pharmaceuticals Inc. In June 2008 Encysive was acquired by Pfi zer Inc.
    3. ORIGINAL ARTICLES
    4. REVIEW ARTICLE
    5. ORIGINAL ARTICLE
    6. REVIEW ARTICLE
    7. ORIGINAL ARTICLES
    8. REVIEW ARTICLES
    9. ORIGINAL ARTICLE
    1. You have free access to this content
      Endothelin receptor selectivity in chronic renal failure (pages 32–37)

      L. Longaretti and A. Benigni

      Version of Record online: 24 MAR 2009 | DOI: 10.1111/j.1365-2362.2009.02119.x

      Corrected by:

      Erratum

      Vol. 39, Issue 7, 630, Version of Record online: 5 JUN 2009

  6. ORIGINAL ARTICLES

    1. Top of page
    2. Update on endothelin-related diseases This Supplement was sponsored by an unrestricted educational grant from Encysive Pharmaceuticals Inc. In June 2008 Encysive was acquired by Pfi zer Inc.
    3. ORIGINAL ARTICLES
    4. REVIEW ARTICLE
    5. ORIGINAL ARTICLE
    6. REVIEW ARTICLE
    7. ORIGINAL ARTICLES
    8. REVIEW ARTICLES
    9. ORIGINAL ARTICLE
  7. REVIEW ARTICLES

    1. Top of page
    2. Update on endothelin-related diseases This Supplement was sponsored by an unrestricted educational grant from Encysive Pharmaceuticals Inc. In June 2008 Encysive was acquired by Pfi zer Inc.
    3. ORIGINAL ARTICLES
    4. REVIEW ARTICLE
    5. ORIGINAL ARTICLE
    6. REVIEW ARTICLE
    7. ORIGINAL ARTICLES
    8. REVIEW ARTICLES
    9. ORIGINAL ARTICLE
    1. You have free access to this content
      Bleeding events in pulmonary arterial hypertension (pages 68–73)

      C. F. Opitz, W. Kirch, E. A. Mueller and D. Pittrow

      Version of Record online: 24 MAR 2009 | DOI: 10.1111/j.1365-2362.2009.02122.x

    2. You have free access to this content
      Endothelin receptor antagonism and cancer (pages 74–77)

      A. Bhalla, S. Haque, I. Taylor, M. Winslet and M. Loizidou

      Version of Record online: 24 MAR 2009 | DOI: 10.1111/j.1365-2362.2009.02123.x

      Corrected by:

      Erratum

      Vol. 39, Issue 7, 630, Version of Record online: 5 JUN 2009

  8. ORIGINAL ARTICLE

    1. Top of page
    2. Update on endothelin-related diseases This Supplement was sponsored by an unrestricted educational grant from Encysive Pharmaceuticals Inc. In June 2008 Encysive was acquired by Pfi zer Inc.
    3. ORIGINAL ARTICLES
    4. REVIEW ARTICLE
    5. ORIGINAL ARTICLE
    6. REVIEW ARTICLE
    7. ORIGINAL ARTICLES
    8. REVIEW ARTICLES
    9. ORIGINAL ARTICLE

SEARCH

SEARCH BY CITATION